Patents by Inventor Allen McClay

Allen McClay has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOUNDS AND COMPOSITIONS USEFUL IN THE TREATMENT OF NEOPLASIA
    Publication number: 20090047221
    Abstract: There is described compounds for use in therapy, said compounds being defined by Formula (1): There is also described an anti-proliferative composition comprising one or more compounds according to Formula (1), and a method of treatment of neoplasia comprising the administration of such a compound or composition.
    Type: Application
    Filed: October 31, 2004
    Publication date: February 19, 2009
    Applicant: NIPRI LIMITED
    Inventors: Allen McClay, David Waugh, Paul Armstrong, Zoica Delbederi, Catherine Higgins, Hendrik Van Den Berg, Patrick Johnston, William Watters, Kelly McGarel, Timothy Mils
  • Intravaginal drug delivery devices for the administration of 17.beta.-oestradiol precursors
    Patent number: 5855906
    Abstract: The invention relates to an intravaginal drug delivery device for administration to a female mammal of certain 17.beta.-oestradiol precursors at a substantially constant rate for a period of at least three weeks. The 17.beta.-oestradiol precursor is a 17.beta.-oestradiol moiety in which the, or each, hydroxyl group of the 17.beta.-oestradiol moiety is blocked by a blocking group, which blocking group is readily removed from the 17.beta.-oestradiol in vivo. The 17.beta.-oestradiol precursor must have either a solubility in liquid silicone of not less than 0.1 mg/100 ml or a standard k value of not less than 0.1 .mu.g/day/mm. The 17.beta.-oestradiol precursor must also have a solubility in distilled water of not less than 1 .mu.g/100 ml.
    Type: Grant
    Filed: June 3, 1997
    Date of Patent: January 5, 1999
    Assignee: Galen (Chemicals) Limited
    Inventor: Allen McClay